Cite
Discovery of Stereospecific PARP‑1 Inhibitor Isoindolinone NMS-P515.
MLA
Papeo, Gianluca, et al. “Discovery of Stereospecific PARP‑1 Inhibitor Isoindolinone NMS-P515.” ACS Medicinal Chemistry Letters, vol. 10, no. 4, Apr. 2019, pp. 534–38. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.8b00569.
APA
Papeo, G., Orsini, P., Avanzi, N. R., Borghi, D., Casale, E., Ciomei, M., Cirla, A., Desperati, V., Donati, D., Felder, E. R., Galvani, A., Guanci, M., Isacchi, A., Posteri, H., Rainoldi, S., Riccardi-Sirtori, F., Scolaro, A., & Montagnoli, A. (2019). Discovery of Stereospecific PARP‑1 Inhibitor Isoindolinone NMS-P515. ACS Medicinal Chemistry Letters, 10(4), 534–538. https://doi.org/10.1021/acsmedchemlett.8b00569
Chicago
Papeo, Gianluca, Paolo Orsini, Nilla R. Avanzi, Daniela Borghi, Elena Casale, Marina Ciomei, Alessandra Cirla, et al. 2019. “Discovery of Stereospecific PARP‑1 Inhibitor Isoindolinone NMS-P515.” ACS Medicinal Chemistry Letters 10 (4): 534–38. doi:10.1021/acsmedchemlett.8b00569.